Lisa Anson

Chief Executive Officer

Experienced General Manager, former President of AstraZeneca UK and has significant leadership experience in pharmaceuticals

Dr. Richard Armer

Chief Scientific Officer

Experienced drug discovery executive, ex Pfizer, Organon, Ardana, Oxagen, Lectus Therapeutics

Andrew Booth

Group Financial Controller

Experienced Financial Controller of listed companies

Peter Collum

Chief Financial Officer

Experienced biopharma finance and strategy executive, previously CFO and CBO of Pharnext SA

Dr. Cliff Jones

Senior Vice President, Chemistry, DMPK and Intellectual Property

Experienced medicinal chemist with broad drug discovery expertise, previously with AstraZeneca in the UK and France

Dr. James Mead

Chief Operating Officer

Previously CFO of AstraZeneca Netherlands, with wide sector experience

Caitlin Pearson

Head of Communications

A strategic communications specialist with AIM-listed biotech experience

Dr. Caroline Phillips

Senior Vice President, Biology

Extensive experience in drug discovery and early clinical development

Dr. Jane Robertson

Chief Medical Officer

Experienced oncology drug developer ex. AstraZeneca, Achilles, Nucana. Led the successful clinical development of Lynparza

Claire Solk

General Counsel & Company Secretary

Legal counsel with extensive life sciences experience

Craig Tilston

Craig Tilston

Head of Development Operations

Experienced drug developer ex. AstraZeneca and Pfizer. Closely involved with the development of a number of successful compounds including Tagrisso™, Lipitor™, Champix™ and Viagra™

Helen Timmis

Vice President, Senior Medical Director

Clinical physician with extensive experience in drug development

Duncan Young

Head of Business Development

Experienced life sciences business development professional with public and private sector experience